AKT1 and neoplasm: The inhibitory effects of hydroxytyrosol administration on tumor growth against several tumor cell lines have been also described in a growing number of studies, likely involving inactivation of the AKT and nuclear-factor-kappa B (NFκB) [23] or other pathways [24,25].